GC녹십자 그룹 내 세포·유전자치료제 전문 개발사 지씨셀(GC Cell)의 R&D pipeline, 연구개발, CDMO, 상업화/유통 역량 소개
近日,GC Cell宣布与Checkpoint Therapeutics(以下简称“Checkpoint”)达成战略合作,共同探索Checkpoint公司的cosibelimab(抗PD-L1抗体)与GC Cell的Immuncell-LC(自体T细胞疗法)进行联合治疗的潜力。 新闻稿指出,此次合作将首先在体外进行联合研究,以评...
GC Cell Corp (144510) 科斯达克 创建提醒 一次 % 添加至投资组合 23,150+650+2.89% 08:19:33- 延迟数据.KRW货币 类型:股票 市场:韩国 ISIN:KR7144510005 量:8,370 卖价/买价:23,100/23,150 当日幅度:22,500-23,200 近期报价 名称价格涨跌额涨跌幅 ...
GC Cell的价格 / 最近12个月的自由现金流于December 2019触及5年低点,是-65.5x。 GC Cell的价格 / 最近12个月的自由现金流于2021 (106.8x, -89.3%)和2022 (14.6x, -86.4%)减少和于2020 (1,000.8x, -1,627.0%)和2023 (175.1x, +1,102.0%)增加。
GC Cell上季度的 营运资本净额为31.695十亿。 Décembre 2019至2023的财年GC Cell的营运资本净额为 10.077十亿 Décembre 2019至 2023的财年,GC Cell的营运资本净额中值为2.48十亿。 过去5年,GC Cell的营运资本净额在septembre 2024达到了 31.695十亿的峰值。 GC Cell的营运资本净额于décembre 2020触及5年低点,是-1.5...
“As the first-ever overseas event for a cell therapy created in Korea, this symposium marks is a significant milestone for the industry,” said a GC Cell spokesperson. “By building trust and visibility in the Indonesian market, we are accelerating the global commercialization of Imm...
“2023 will mark a new beginning for GC Cell, determining sustainable growth of our business”, said James Park, the new CEO. He added, “the company will focus on delivering performance, and the new management team will take the lead in setting and executing strong implementation guidelines ...
检查站,GC Cell评估联合癌症疗法 Checkpoint Therapeutics(CKPT) stem(STEM)0.4422-8.41% Checkpoint Therapeutics (NASDAQ:CKPT) and South Korea's GC Cell will collaborate on a combination treatment of the former's cosibelimab, an anti-PD-L1 antibody, and the latter's Immuncell-LC, a T-cell ...
Checkpoint Therapeutics (NASDAQ:CKPT) and South Korea's GC Cell will collaborate on a combination treatment of the former's cosibelimab, an anti-PD-L1 antibody, and the latter's Immuncell-LC, a T-cell therapy. At the outset, the work will focus on in vitro studies to examine synergistic...
近日,美国纽约洛克菲勒大学分子免疫学实验室的研究团队在杂志《Cell》上发表了研究型的文章“Continuous germinal center invasion contributes to the diversity of the immune response”(持续的生发中心侵袭有助于免疫反应的多样性)。他们描述了谱系追踪实验,其中在GC反应期间追踪多克隆幼稚B细胞的命运。